Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
- Submitting institution
-
The University of East Anglia
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 182585178
- Type
- D - Journal article
- DOI
-
10.1016/S1470-2045(15)00086-8
- Title of journal
- The Lancet Oncology
- Article number
- -
- First page
- 928
- Volume
- 16
- Issue
- 8
- ISSN
- 1470-2045
- Open access status
- Out of scope for open access requirements
- Month of publication
- August
- Year of publication
- 2015
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
23
- Research group(s)
-
-
- Citation count
- 352
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- The author made a substantial contribution to the conception and design of the study; and to the organisation of the conduct of the study; and to analysis and interpretation of study data; and helped draft the output.
- Non-English
- No
- English abstract
- -
